A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018.

• Autores principales: Gabriela A Willis (Autor), Helen J Mayfield (Autor), Therese Kearns (Autor), Take Naseri (Autor), Robert Thomsen (Autor), Katherine Gass (Autor), Sarah Sheridan (Autor), Patricia M Graves (Autor), Colleen L Lau (Autor)
• Formato: Libro
• Publicado: Public Library of Science (PLoS), 2020-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

The Global Programme to Eliminate Lymphatic Filariasis has made considerable progress but is experiencing challenges in meeting targets in some countries. Recent World Health Organization guidelines have recommended two rounds of triple-drug therapy with ivermectin, diethylcarbamazine (DEC), and alb...